Chinese Patent Medicine Industry: Global Market Opportunities and Forecast 2021-2027

Chinese Patent Medicine Industry: Global Market Opportunities and Forecast 2021-2027

Report Code: KNJ1014717 | No. of Pages: 167 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Nov-2021
This report provides a comprehensive analysis of current global Chinese Patent Medicine market based on segmented types and downstream applications. Major product development trends are discussed  under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Chinese Patent Medicine industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Chinese Patent Medicine market is estimated to have reached $  million in 2020, and projected to grow at a CAGR of % to $  million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Chinese Patent Medicine Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Chinese Patent Medicine market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Chinese Patent Medicine Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Chinese Patent Medicine industry. 
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis. 
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
    Syrup

    Liquid


Segmented by Application
    Online Sales

    Offline Sales

Segmented by Country
    North America
        United States
        Canada
        Mexico
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
    Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
    Central & South America
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

Key manufacturers included in this survey
    Taiji Group Co., Ltd.

    Shijiazhuang Pharmaceutical Group Co., Ltd.

    Shanghai Pharmaceutical (Group) Co., Ltd.

    Northeast Pharmaceutical Group Co., Ltd.

    North China Pharmaceutical Group Co., Ltd.

    Nanjing Pharmaceutical Industry (Group) Co., Ltd.

    Nanjing Pharmaceutical Co., Ltd

    Jiangxi Pharmaceutical Group Corporation

    Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.

    Harbin Pharmaceutical Group Co., Ltd

    Hangzhou Huadong Pharmaceutical Group Co., Ltd.

    Guangzhou Pharmaceutical Group Co., Ltd.

    Chongqing Pharmaceutical Co., Ltd

    China Pharmaceutical Group Corporation



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Chinese Patent Medicine Market Status and Forecast (2016-2027)
        1.3.2 Global Chinese Patent Medicine Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Chinese Patent Medicine Supply by Company
    2.1 Global Chinese Patent Medicine Sales Volume by Company
    2.2 Global Chinese Patent Medicine Sales Value by Company
    2.3 Global Chinese Patent Medicine Price by Company
    2.4 Chinese Patent Medicine Production Location and Sales Area of Main Manufacturers
    2.5 Trend of Concentration Rate
3 Global and Regional Chinese Patent Medicine Market Status by Type
    3.1 Chinese Patent Medicine Type Introduction
        3.1.1 Syrup

        3.1.2 Liquid

        3.1.3 Tablet

        3.1.4 Others
    3.2 Global Chinese Patent Medicine Market by Type
        3.2.1 Global Chinese Patent Medicine Sales Volume by Type (2016-2021)
        3.2.2 Global Chinese Patent Medicine Sales Value by Type (2016-2021)
        3.2.3 Global Chinese Patent Medicine Price by Type (2016-2021)
    3.3 North America: by Type
    3.4 Europe: by Type
    3.5 Asia Pacific: by Type
    3.6 Central & South America: by Type
    3.7 Middle East & Africa: by Type
4 Global and Regional Chinese Patent Medicine Market Status by Application
    4.1 Chinese Patent Medicine Segment by Application
        4.1.1 Online Sales

        4.1.2 Offline Sales
    4.2 Global Chinese Patent Medicine Market by Application
        4.2.1 Global Chinese Patent Medicine Sales Volume by Application (2016-2021)
        4.2.2 Global Chinese Patent Medicine Sales Value by Application (2016-2021)
        4.2.3 Global Chinese Patent Medicine Price by Application (2016-2021)
    4.3 North America: by Application
    4.4 Europe: by Application
    4.5 Asia Pacific: by Application
    4.6 Central & South America: by Application
    4.7 Middle East & Africa: by Application
5 Global Chinese Patent Medicine Market Status by Region
    5.1 Global Chinese Patent Medicine Market by Region
        5.1.1 Global Chinese Patent Medicine Sales Volume by Region
        5.1.2 Global Chinese Patent Medicine Sales Value by Region
    5.2 North America Chinese Patent Medicine Market Status
    5.3 Europe Chinese Patent Medicine Market Status
    5.4 Asia Pacific Chinese Patent Medicine Market Status
    5.5 Central & South America Chinese Patent Medicine Market Status
    5.6 Middle East & Africa Chinese Patent Medicine Market Status
6 North America Chinese Patent Medicine Market Status
    6.1 North America Chinese Patent Medicine Market by Country
        6.1.1 North America Chinese Patent Medicine Sales Volume by Country (2016-2021)
        6.1.2 North America Chinese Patent Medicine Sales Value by Country (2016-2021)
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Chinese Patent Medicine Market Status
    7.1 Europe Chinese Patent Medicine Market by Country
        7.1.1 Europe Chinese Patent Medicine Sales Volume by Country (2016-2021)
        7.1.2 Europe Chinese Patent Medicine Sales Value by Country (2016-2021)
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Chinese Patent Medicine Market Status
   8.1 Asia Pacific Chinese Patent Medicine Market by Country
        8.1.1 Asia Pacific Chinese Patent Medicine Sales Volume by Country (2016-2021)
        8.1.2 Asia Pacific Chinese Patent Medicine Sales Value by Country (2016-2021)
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Chinese Patent Medicine Market Status
    9.1 Central & South America Chinese Patent Medicine Market by Country
        9.1.1 Central & South America Chinese Patent Medicine Sales Volume by Country (2016-2021)
        9.1.2 Central & South America Chinese Patent Medicine Sales Value by Country (2016-2021)
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Chinese Patent Medicine Market Status
    10.1 Middle East & Africa Chinese Patent Medicine Market by Country
        10.1.1 Middle East & Africa Chinese Patent Medicine Sales Volume by Country (2016-2021)
        10.1.2 Middle East & Africa Chinese Patent Medicine Sales Value by Country (2016-2021)
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
    11.1 Supply Chain Analysis
    11.2 Production Process Chart Analysis
    11.3 Raw Materials and Key Suppliers Analysis
        11.3.1 Raw Materials Introduction
        11.3.2 Raw Materials Key Suppliers List
    11.4 Chinese Patent Medicine Manufacturing Cost Analysis
    11.5 Chinese Patent Medicine Sales Channel and Distributors Analysis
        11.5.1 Chinese Patent Medicine Sales Channel
        11.5.2 Chinese Patent Medicine Distributors
    11.6 Chinese Patent Medicine Downstream Major Buyers
12 Global Chinese Patent Medicine Market Forecast by Type and by Application
    12.1 Global Chinese Patent Medicine Sales Volume and Sales Value Forecast (2022-2027)
    12.2 Global Chinese Patent Medicine Forecast by Type
        12.2.1 Global Chinese Patent Medicine Sales Volume Forecast by Type
        12.2.2 Global Chinese Patent Medicine Sales Value Forecast by Type
        12.2.3 Global Chinese Patent Medicine Price Forecast by Type
    12.3 Global Chinese Patent Medicine Forecast by Application
        12.3.1 Global Chinese Patent Medicine Sales Volume Forecast by Application
        12.3.2 Global Chinese Patent Medicine Sales Value Forecast by Application
        12.3.3 Global Chinese Patent Medicine Price Forecast by Application
13 Global Chinese Patent Medicine Market Forecast by Region/Country
    13.1 Global Chinese Patent Medicine Market Forecast by Region (2022-2027)
        13.1.1 Global Chinese Patent Medicine Sales Volume Forecast by Region (2022-2027)
        13.1.2 Global Chinese Patent Medicine Sales Value Forecast by Region (2022-2027)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd.

        14.1.1 Company Information
        14.1.2 Chinese Patent Medicine Product Introduction
        14.1.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
 Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.1.4 SWOT Analysis
    14.2 Tianjin Pharmaceutical Group Co., Ltd.

        14.2.1 Company Information
        14.2.2 Chinese Patent Medicine Product Introduction
        14.2.3 Tianjin Pharmaceutical Group Co., Ltd.
 Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.2.4 SWOT Analysis
    14.3 Taiji Group Co., Ltd.

        14.3.1 Company Information
        14.3.2 Chinese Patent Medicine Product Introduction
        14.3.3 Taiji Group Co., Ltd.
 Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.3.4 SWOT Analysis
    14.4 Shijiazhuang Pharmaceutical Group Co., Ltd.

        14.4.1 Company Information
        14.4.2 Chinese Patent Medicine Product Introduction
        14.4.3 Shijiazhuang Pharmaceutical Group Co., Ltd.
 Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.4.4 SWOT Analysis
    14.5 Shanghai Pharmaceutical (Group) Co., Ltd.

        14.5.1 Company Information
        14.5.2 Chinese Patent Medicine Product Introduction
        14.5.3 Shanghai Pharmaceutical (Group) Co., Ltd.
 Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.5.4 SWOT Analysis
    14.6 Northeast Pharmaceutical Group Co., Ltd.

        14.6.1 Company Information
        14.6.2 Chinese Patent Medicine Product Introduction
        14.6.3 Northeast Pharmaceutical Group Co., Ltd.
 Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.6.4 SWOT Analysis
    14.7 North China Pharmaceutical Group Co., Ltd.

        14.7.1 Company Information
        14.7.2 Chinese Patent Medicine Product Introduction
        14.7.3 North China Pharmaceutical Group Co., Ltd.
 Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.7.4 SWOT Analysis
    14.8 Nanjing Pharmaceutical Industry (Group) Co., Ltd.

        14.8.1 Company Information
        14.8.2 Chinese Patent Medicine Product Introduction
        14.8.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
 Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.8.4 SWOT Analysis
    14.9 Nanjing Pharmaceutical Co., Ltd

        14.9.1 Company Information
        14.9.2 Chinese Patent Medicine Product Introduction
        14.9.3 Nanjing Pharmaceutical Co., Ltd
 Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.9.4 SWOT Analysis
    14.10 Jiangxi Pharmaceutical Group Corporation

        14.10.1 Company Information
        14.10.2 Chinese Patent Medicine Product Introduction
        14.10.3 Jiangxi Pharmaceutical Group Corporation
 Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.10.4 SWOT Analysis
    14.11 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.

    14.12 Harbin Pharmaceutical Group Co., Ltd

    14.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.

    14.14 Guangzhou Pharmaceutical Group Co., Ltd.

    14.15 Chongqing Pharmaceutical Co., Ltd

    14.16 China Pharmaceutical Group Corporation

15 Conclusion
16 Methodology

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com